{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T02:53:57Z","timestamp":1774580037202,"version":"3.50.1"},"reference-count":120,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Rheumatoid arthritis (RA) is an inflammatory and autoimmune disease. Studies over the past two decades suggest that statins have a beneficial impact on the complications associated with RA. These complications include RA disease activity and risk for cardiovascular diseases (CVD). This review aims to discuss the efficacy of statin therapy in RA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>The current evidence suggests that statins' immunomodulatory and antioxidant properties significantly reduce disease activity and inflammatory response in patients with RA. In RA patients, the risk of CVD is reduced by statin treatment, and statin discontinuation is associated with an increased cardiovascular disease risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Summary<\/jats:title>\n                  <jats:p>The combined effect of statins on improving vascular function, lowering lipid levels, and reducing inflammation in RA patients is responsible for the decreased all-cause mortality in statin users. Further clinical studies are needed to ensure the therapeutic efficacy of statins in patients with RA.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jpp\/rgad024","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T16:48:48Z","timestamp":1680886128000},"page":"910-920","source":"Crossref","is-referenced-by-count":15,"title":["The pleiotropic effects of statins in <i>rheumatoid arthritis<\/i>"],"prefix":"10.1093","volume":"75","author":[{"given":"Elham","family":"Aminifar","sequence":"first","affiliation":[{"name":"Student Research Committee, Islamic Azad University, Mashhad Branch , Mashhad ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haleh Sadat","family":"Tavakkol Afshari","sequence":"additional","affiliation":[{"name":"Department of Biology, Mashhad Branch, Islamic Azad University , Mashhad ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-2231","authenticated-orcid":false,"given":"Thozhukat","family":"Sathyapalan","sequence":"additional","affiliation":[{"name":"Department of Academic Diabetes, Endocrinology and Metabolism, Hull York Medical School, University of Hull , Hull ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4670-7127","authenticated-orcid":false,"given":"Mitra","family":"Abbasifard","sequence":"additional","affiliation":[{"name":"Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences , Rafsanjan ,","place":["Iran"]},{"name":"Department of Internal Medicine, Ali-Ibn Abi-Talib Hospital, School of Medicine, Rafsanjan University of Medical Sciences , Rafsanjan ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8656-1444","authenticated-orcid":false,"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[{"name":"Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences , Mashhad ,","place":["Iran"]},{"name":"Applied Biomedical Research Center, Mashhad University of Medical Sciences , Mashhad ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,7,1]]},"reference":[{"key":"2024103012241007700_CIT0001","first-page":"102","article-title":"Clustering of cardiovascular risk factors in rheumatoid arthritis: the rationale for using statins","volume":"25","author":"Gazi","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"2024103012241007700_CIT0002","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","article-title":"Epidemiology of adult rheumatoid arthritis","volume":"4","author":"Alamanos","year":"2005","journal-title":"Autoimmun Rev"},{"key":"2024103012241007700_CIT0003","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.bor.0000218951.65601.bf","article-title":"Cardiovascular disease in rheumatoid arthritis","volume":"18","author":"Kaplan","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"2024103012241007700_CIT0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2005.03.004","article-title":"Rheumatoid arthritis: a disease associated with accelerated atherogenesis.","volume-title":"Semin Arthritis Rheum","author":"Gonzalez-Gay","year":"2005"},{"key":"2024103012241007700_CIT0005","first-page":"8","article-title":"Therapies for bone R","volume":"30173","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"2024103012241007700_CIT0006","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"key":"2024103012241007700_CIT0007","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3899\/jrheum.130365","article-title":"Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study","volume":"40","author":"Ajeganova","year":"2013","journal-title":"J Rheumatol"},{"key":"2024103012241007700_CIT0008","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised controlled trials of statins (vol 366, pg 1267, 2005)","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"2024103012241007700_CIT0009","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"The Lancet"},{"key":"2024103012241007700_CIT0010","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","article-title":"Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial\u2014Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial","volume":"361","author":"Sever","year":"2003","journal-title":"The Lancet"},{"key":"2024103012241007700_CIT0011","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11745-010-3517-x","article-title":"Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial","volume":"46","author":"Parizadeh","year":"2011","journal-title":"Lipids"},{"key":"2024103012241007700_CIT0012","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2015.05.022","article-title":"Statin therapy reduces plasma endothelin-1 concentrations: a meta-analysis of 15 randomized controlled trials","volume":"241","author":"Sahebkar","year":"2015","journal-title":"Atherosclerosis"},{"key":"2024103012241007700_CIT0013","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1160\/TH14-11-0937","article-title":"Association between statin use and plasma d-dimer levels: a systematic review and meta-analysis of randomised controlled trials","volume":"114","author":"Sahebkar","year":"2015","journal-title":"Thromb Haemost"},{"key":"2024103012241007700_CIT0014","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1160\/th15-08-0620","article-title":"The impact of statin therapy on plasma levels of von Willebrand factor antigen: systematic review and meta-analysis of randomised placebo-controlled trials","volume":"115","author":"Sahebkar","year":"2016","journal-title":"Thromb Haemost"},{"key":"2024103012241007700_CIT0015","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.5114\/aoms.2019.89330","article-title":"Effect of atorvastatin on delirium status of patients in the intensive care unit: a randomized controlled trial.","volume":"17","author":"Sohrevardi","year":"2021","journal-title":"Archives of Medical Science."},{"key":"2024103012241007700_CIT0016","doi-asserted-by":"crossref","first-page":"579","DOI":"10.5114\/aoms\/132950","article-title":"Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: a systematic review and meta-analysis.","volume":"17","author":"Vahedian-Azimi","year":"2021","journal-title":"Arch Med Sci"},{"key":"2024103012241007700_CIT0017","doi-asserted-by":"crossref","first-page":"101024","DOI":"10.1016\/j.arr.2020.101024","article-title":"Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ageing: molecular mechanisms","volume":"58","author":"Bahrami","year":"2020","journal-title":"Ageing Res Rev"},{"key":"2024103012241007700_CIT0018","doi-asserted-by":"crossref","first-page":"105986","DOI":"10.1016\/j.phrs.2021.105986","article-title":"The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury","volume":"175","author":"Bland","year":"2022","journal-title":"Pharmacol Res"},{"key":"2024103012241007700_CIT0019","doi-asserted-by":"crossref","first-page":"106284","DOI":"10.1016\/j.ejps.2022.106284","article-title":"Effect of statins on abdominal aortic aneurysm","volume":"178","author":"Hosseini","year":"2022","journal-title":"Eur J Pharm Sci"},{"key":"2024103012241007700_CIT0020","doi-asserted-by":"crossref","first-page":"101049","DOI":"10.1016\/j.molmet.2020.101049","article-title":"Non-alcoholic fatty liver disease and steatohepatitis: state of the art on effective therapeutics based on the gold standard method for diagnosis","volume":"50","author":"Mahjoubin-Tehran","year":"2021","journal-title":"Mol Metab"},{"key":"2024103012241007700_CIT0021","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.plipres.2014.07.002","article-title":"Recent advances in pharmacotherapy for hypertriglyceridemia","volume":"56","author":"Sahebkar","year":"2014","journal-title":"Prog Lipid Res"},{"key":"2024103012241007700_CIT0022","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(09)60447-5","article-title":"Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial","volume":"373","author":"Ridker","year":"2009","journal-title":"Lancet"},{"key":"2024103012241007700_CIT0023","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomised placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"key":"2024103012241007700_CIT0024","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tcm.2005.07.002","article-title":"Toward immunomodulatory and anti-inflammatory properties of statins","volume":"15","author":"Arnaud","year":"2005","journal-title":"Trends Cardiovasc Med"},{"key":"2024103012241007700_CIT0025","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3109\/s10165-007-0589-4","article-title":"Effects of low-dosage simvastatin on rheumatoid arthritis through reduction of Th1\/Th2 and CD4\/CD8 ratios","volume":"17","author":"Kanda","year":"2007","journal-title":"Mod Rheumatol"},{"key":"2024103012241007700_CIT0026","first-page":"1083","article-title":"Bone protective effect of simvastatin in experimental arthritis","volume":"35","author":"Funk","year":"2008","journal-title":"J Rheumatol"},{"key":"2024103012241007700_CIT0027","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2125.2009.03560.x","article-title":"Is there an anti-inflammatory effect of statins in rheumatoid arthritis? Analysis of a large routinely collected claims database","volume":"69","author":"Lodi","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"2024103012241007700_CIT0028","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.autrev.2017.10.013","article-title":"The anti-inflammatory effects of statins on patients with rheumatoid arthritis: a systemic review and meta-analysis of 15 randomized controlled trials","volume":"17","author":"G-m","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2024103012241007700_CIT0029","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/rheumatology\/kel344","article-title":"Atorvastatine for chronic synovitis due to massive intra-articular cholesterol monohydrate deposition in long-standing rheumatoid arthritis","volume":"45","author":"Jansen","year":"2006","journal-title":"Rheumatology"},{"key":"2024103012241007700_CIT0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/187152208785748322","article-title":"\u201cCardiovascular\u201d drugs in rheumatoid arthritis: killing two birds with one stone?","volume":"8","author":"Toms","year":"2008","journal-title":"Immunol, Endocr Metab Agents Med Chem"},{"key":"2024103012241007700_CIT0031","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s12265-020-09964-9","article-title":"Cardiovascular risk assessment and therapeutic implications in rheumatoid arthritis","volume":"13","author":"Halacoglu","year":"2020","journal-title":"J Cardiovasc Transl Res"},{"key":"2024103012241007700_CIT0032","first-page":"s49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff Jr","year":"2014","journal-title":"Circulation"},{"key":"2024103012241007700_CIT0033","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2017-211735","article-title":"A Trans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA): impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis","volume":"77","author":"Crowson","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2024103012241007700_CIT0034","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/annrheumdis-2013-204792","article-title":"Cardiovascular disease assessment in rheumatoid arthritis: a guide to translating knowledge of cardiovascular risk into clinical practice","volume":"73","author":"Semb","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2024103012241007700_CIT0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/157016110791112269","article-title":"Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors","volume":"8","author":"Toms T","year":"2010","journal-title":"Curr Vasc Pharmacol"},{"key":"2024103012241007700_CIT0036","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/ard.2009.115717","article-title":"Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?","volume":"69","author":"Toms","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2024103012241007700_CIT0037","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3899\/jrheum.160110","article-title":"Cardiovascular outcomes associated with lowering low-density lipoprotein cholesterol in rheumatoid arthritis and matched nonrheumatoid arthritis","volume":"43","author":"An","year":"2016","journal-title":"J Rheumatol"},{"key":"2024103012241007700_CIT0038","doi-asserted-by":"crossref","first-page":"S462","DOI":"10.1086\/315611","article-title":"Infection and inflammation-induced proatherogenic changes of lipoproteins","volume":"181","author":"Khovidhunkit","year":"2000","journal-title":"J Infect Dis"},{"key":"2024103012241007700_CIT0039","first-page":"2700","article-title":"Evaluation of the anti-inflammatory effects of atorvastatin on patients with rheumatoid arthritis: a randomized clinical trial","volume":"8","author":"Sarabi","year":"2016","journal-title":"Electr Phys"},{"key":"2024103012241007700_CIT0040","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"2024103012241007700_CIT0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-014-0497-6","article-title":"Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship?","volume":"15","author":"Bag-Ozbek","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"2024103012241007700_CIT0042","doi-asserted-by":"crossref","first-page":"e001588","DOI":"10.1161\/JAHA.114.001588","article-title":"The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis","volume":"4","author":"Liao","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2024103012241007700_CIT0043","first-page":"e0164564e0164564","article-title":"Patients with rheumatoid arthritis show altered lipoprotein profiles with dysfunctional high-density lipoproteins that can exacerbate inflammatory and atherogenic process","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS One"},{"key":"2024103012241007700_CIT0044","first-page":"1459","article-title":"Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study","volume":"34","author":"Charles-Schoeman","year":"2007","journal-title":"J Rheumatol"},{"key":"2024103012241007700_CIT0045","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1172\/JCI10852","article-title":"Statin-induced inhibition of the Rho-signaling pathway activates PPAR\u03b1 and induces HDL apoA-I","volume":"107","author":"Martin","year":"2001","journal-title":"J Clin Invest"},{"key":"2024103012241007700_CIT0046","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2008.104497","volume-title":"Dyslipidaemia, Statins and Rheumatoid Arthritis","author":"Nurmohamed","year":"2009"},{"key":"2024103012241007700_CIT0047","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fmed.2018.00024","article-title":"The role of statins in disease modification and cardiovascular risk in rheumatoid arthritis","volume":"5","author":"Soulaidopoulos","year":"2018","journal-title":"Front Medicine"},{"key":"2024103012241007700_CIT0048","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s10067-015-3049-0","article-title":"Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment","volume":"34","author":"Akiyama","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2024103012241007700_CIT0049","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/03009742.2011.586649","article-title":"Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial","volume":"40","author":"Tam","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"2024103012241007700_CIT0050","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jacc.2004.11.006","article-title":"Simvastatin improves endothelial function in patients with rheumatoid arthritis","volume":"45","author":"Hermann","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2024103012241007700_CIT0051","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/acr.22029","article-title":"Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non\u2013rheumatoid arthritis subjects: results from a population-based study","volume":"65","author":"Myasoedova","year":"2013","journal-title":"Arthritis Care Research"},{"key":"2024103012241007700_CIT0052","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1136\/ard.2003.018333","article-title":"Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis","volume":"63","author":"Van Doornum","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"2024103012241007700_CIT0053","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/annrheumdis-2012-202442","article-title":"Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study","volume":"73","author":"McInnes","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2024103012241007700_CIT0054","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.36740\/WLek202011117","article-title":"The effect of atorvastatinum in the treatment of patients with rheumatoid arthritis","volume":"73","author":"Shevchuk","year":"2020","journal-title":"Wiad Lek"},{"key":"2024103012241007700_CIT0055","doi-asserted-by":"crossref","first-page":"e13566","DOI":"10.14814\/phy2.13566","article-title":"Statins decrease leptin expression in human white adipocytes","volume":"6","author":"Singh","year":"2018","journal-title":"Physiol Rep"},{"key":"2024103012241007700_CIT0056","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/bcp.13086","article-title":"Impact of statin therapy on plasma leptin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"82","author":"Sahebkar","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"2024103012241007700_CIT0057","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3899\/jrheum.100582","article-title":"Effect of atorvastatin on inflammation and modification of vascular risk factors in rheumatoid arthritis","volume":"38","author":"El-Barbary","year":"2011","journal-title":"J Rheumatol"},{"key":"2024103012241007700_CIT0058","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/hepr.12821","article-title":"Rosuvastatin limits the activation of hepatic stellate cells in diet-induced obese mice.","volume":"47","author":"Marinho","year":"2017","journal-title":"Hepatol Res"},{"key":"2024103012241007700_CIT0059","doi-asserted-by":"crossref","first-page":"105264","DOI":"10.1016\/j.ejps.2020.105264","article-title":"Rheumatoid arthritis downregulates the drug transporter OATP1B1: fluvastatin as a probe","volume":"146","author":"Caris","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"2024103012241007700_CIT0060","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejphar.2005.05.005","article-title":"Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis","volume":"516","author":"Barsante","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"2024103012241007700_CIT0061","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4049\/jimmunol.170.3.1524","article-title":"A novel anti-inflammatory role for simvastatin in inflammatory arthritis","volume":"170","author":"Leung","year":"2003","journal-title":"J Immunol"},{"key":"2024103012241007700_CIT0062","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.5114\/aoms\/141155","article-title":"Statins as anti-pyroptotic agents.","volume":"17","author":"Khalifeh","year":"2021","journal-title":"Archives of Medical Science"},{"key":"2024103012241007700_CIT0063","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.5114\/aoms.2020.100304","article-title":"Statins and C-reactive protein: in silico evidence on direct interaction.","volume":"16","author":"Shakour","year":"2020","journal-title":"Arch Med Sci"},{"key":"2024103012241007700_CIT0064","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","article-title":"Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways","volume":"60","author":"Koushki","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"2024103012241007700_CIT0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.plipres.2015.08.003","article-title":"Effect of statin therapy on paraoxonase-1 status: a systematic review and meta-analysis of 25 clinical trials","volume":"60","author":"Ferretti","year":"2015","journal-title":"Prog Lipid Res"},{"key":"2024103012241007700_CIT0066","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000439538","article-title":"Protective effects of simvastatin and hesperidin against complete freund\u2019s adjuvant-induced rheumatoid arthritis in rats","volume":"96","author":"Ahmed","year":"2015","journal-title":"Pharmacology"},{"key":"2024103012241007700_CIT0067","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/03009740802572475","article-title":"Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis","volume":"38","author":"Blaschke","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"2024103012241007700_CIT0068","article-title":"Atorvastatin inhibits IL-17A, TNF, IL-6, and IL-10 in PBMC cultures from patients with severe rheumatoid arthritis. Immunobiology. 2020; 225: 151908. https:\/\/doi.org\/10.1016\/j.imbio.2020.151908","author":"de Oliveira"},{"key":"2024103012241007700_CIT0069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-08332-9","article-title":"The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cells","volume":"10","author":"Perucha","year":"2019","journal-title":"Nat Commun"},{"key":"2024103012241007700_CIT0070","first-page":"1","article-title":"Statin modulation of human T-cell proliferation, IL-1 and IL-17 production, and IFN-T cell \u00adexpression: synergy with conventional immunosuppressive agents","volume":"2013","author":"Jameel","year":"2013","journal-title":"Int J Inflamm"},{"key":"2024103012241007700_CIT0071","first-page":"1","article-title":"Interleukin-18 expression in rheumatoid artheritis synovial tissue and its relation to disease activity","volume":"14","author":"Gouda","year":"2007","journal-title":"Egyptian J Immun"},{"key":"2024103012241007700_CIT0072","first-page":"25","article-title":"Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysis","volume-title":"Pharmacoeconomics","author":"Bansback","year":"2009"},{"key":"2024103012241007700_CIT0073","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.0c05054","article-title":"Rosuvastatin attenuates rheumatoid arthritis-associated manifestations via modulation of the pro-and anti-inflammatory cytokine network: a combination of in vitro and in vivo studies","volume-title":"ACS Omega","author":"Qasim","year":"2021"},{"key":"2024103012241007700_CIT0074","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/rheumatology\/kez471","article-title":"A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis","volume":"59","author":"Aranow","year":"2020","journal-title":"Rheumatology"},{"key":"2024103012241007700_CIT0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cca.2016.02.010","article-title":"Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis","volume":"455","author":"Mateen","year":"2016","journal-title":"Clin Chim Acta"},{"key":"2024103012241007700_CIT0076","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nat Med"},{"key":"2024103012241007700_CIT0077","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat Med"},{"key":"2024103012241007700_CIT0078","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/art.21521","article-title":"Statins as antiinflammatory and immunomodulatory agents: a future in rheumatologic therapy?","volume":"54","author":"Abeles","year":"2006","journal-title":"Arthr Rheumatism"},{"key":"2024103012241007700_CIT0079","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/acr.21643","article-title":"Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study","volume":"64","author":"De Vera","year":"2012","journal-title":"Arthritis Care Res"},{"key":"2024103012241007700_CIT0080","first-page":"805","article-title":"Ezetimibe and simvastatin both reduce inflammation, disease activity, aortic stiffness and improve endothelial function in rheumatoid arthritis","volume":"20","author":"Maki-Petaja","year":"2006","journal-title":"J Hum Hypertens"},{"key":"2024103012241007700_CIT0081","doi-asserted-by":"crossref","first-page":"e0153440","DOI":"10.1371\/journal.pone.0153440","article-title":"Sustained improvement of arterial stiffness and blood pressure after long-term rosuvastatin treatment in patients with inflammatory joint diseases: results from the RORA-AS Study","volume":"11","author":"Ikdahl","year":"2016","journal-title":"PLoS One"},{"key":"2024103012241007700_CIT0082","first-page":"1718","article-title":"Rosuvastatin-induced carotid plaque regression in patients with inflammatory joint diseases: the ROsuvastatin in rheumatoid arthritis, ankylosing spondylitis and other inflammatory joint diseases study.","volume":"67","author":"Rollefstad","year":"2015","journal-title":"Arth"},{"key":"2024103012241007700_CIT0083","first-page":"2024","article-title":"Antiinflammatory effect of simvastatin in patients with rheumatoid arthritis","volume":"29","author":"Kanda","year":"2002","journal-title":"J Rheumatol"},{"key":"2024103012241007700_CIT0084","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1191\/0961203303lu429oa","article-title":"Therapy with statins in patients with refractory rheumatic diseases: a preliminary study","volume":"12","author":"Abud-Mendoza","year":"2003","journal-title":"Lupus"},{"key":"2024103012241007700_CIT0085","first-page":"OC32","article-title":"Effect of atorvastatin on the disease activity and severity of rheumatoid arthritis: double-blind randomized controlled trial","volume":"10","author":"Mowla","year":"2016","journal-title":"J Clinical Diagnost Res"},{"key":"2024103012241007700_CIT0086","doi-asserted-by":"crossref","first-page":"e5353","DOI":"10.1097\/MD.0000000000005353","article-title":"Effect of vitamin D3 on self-perceived fatigue: a double-blind randomized placebo-controlled trial","volume":"95","author":"Nowak","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2024103012241007700_CIT0087","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"2024103012241007700_CIT0088","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/rheumatology\/41.3.329","article-title":"The role of TNF-\u03b1 in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA\/SCID mouse chimera","volume":"41","author":"Matsuno","year":"2002","journal-title":"Rheumatology"},{"key":"2024103012241007700_CIT0089","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00011-013-0702-4","article-title":"Simvastatin inhibits cytokines in a dose response in patients with rheumatoid arthritis","volume":"63","author":"Pereira","year":"2014","journal-title":"Inflamm Res"},{"key":"2024103012241007700_CIT0090","first-page":"2095","article-title":"Effects of angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis","volume":"32","author":"Tikiz","year":"2005","journal-title":"J Rheumatol"},{"key":"2024103012241007700_CIT0091","first-page":"69","article-title":"The impact of statins therapy on disease activity and inflammatory factor in patients with rheumatoid arthritis: a meta-analysis","volume":"33","author":"Lv","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"2024103012241007700_CIT0092","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1258\/smj.2012.012004","article-title":"Rosuvastatin might have an effect on C-reactive protein but not on rheumatoid disease activity: Tayside randomized controlled study","volume":"57","author":"Kumar","year":"2012","journal-title":"Scott Med J"},{"key":"2024103012241007700_CIT0093","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/326258","article-title":"The role of simvastatin in the therapeutic approach of rheumatoid arthritis","volume":"2013","author":"Cojocaru","year":"2013","journal-title":"Autoimmune Dis"},{"key":"2024103012241007700_CIT0094","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/art.21564","article-title":"Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis.","volume":"54","author":"Nagashima","year":"2006","journal-title":"Arthr Rheumat"},{"key":"2024103012241007700_CIT0095","volume-title":"Seminars in Arthritis and Rheumatism","author":"Steiner","year":"2009"},{"key":"2024103012241007700_CIT0096","first-page":"1701","article-title":"Lipid profiles in untreated patients with rheumatoid arthritis","volume":"26","author":"Park","year":"1999","journal-title":"J Rheumatol"},{"key":"2024103012241007700_CIT0097","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-015-0459-4","article-title":"Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies","volume":"13","author":"Banach","year":"2015","journal-title":"BMC Med"},{"key":"2024103012241007700_CIT0098","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(03)00239-9","article-title":"Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities","volume":"173","author":"Rosenson","year":"2004","journal-title":"Atherosclerosis"},{"key":"2024103012241007700_CIT0099","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/annrheumdis-2011-201148","article-title":"Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis","volume":"71","author":"Da\u00efen","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2024103012241007700_CIT0100","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0735-1097(97)00353-7","article-title":"Modulation of lipoprotein (a) atherogenicity by high density lipoprotein cholesterol levels in middle-aged men with symptomatic coronary artery disease and normal to moderately elevated serum cholesterol","volume":"30","author":"Cobbaert","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2024103012241007700_CIT0101","first-page":"1219","article-title":"High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis","volume":"32","author":"Gonzalez-Gay","year":"2005","journal-title":"J Rheumatol"},{"key":"2024103012241007700_CIT0102","first-page":"430","article-title":"Prediction of mortality in rheumatoid arthritis based on disease activity markers","volume":"32","author":"Book","year":"2005","journal-title":"J Rheumatol"},{"key":"2024103012241007700_CIT0103","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"70","author":"Myasoedova","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2024103012241007700_CIT0104","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/keq295","article-title":"Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial","volume":"50","author":"Semb","year":"2011","journal-title":"Rheumatology"},{"key":"2024103012241007700_CIT0105","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/1756-185X.12415","article-title":"Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis?","volume":"17","author":"Danninger","year":"2014","journal-title":"International Journal of Rheumatic Diseases"},{"key":"2024103012241007700_CIT0106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2017.11.009","article-title":"Effect of statin therapy on the prevention of new-onset acute coronary syndrome in patients with rheumatoid arthritis","volume":"253","author":"Huang","year":"2018","journal-title":"Int J Cardiol"},{"key":"2024103012241007700_CIT0107","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3899\/jrheum.110318","article-title":"Effectiveness of statins on total cholesterol and cardiovascular disease and all-cause mortality in osteoarthritis and rheumatoid arthritis","volume":"39","author":"Sheng","year":"2012","journal-title":"J Rheumatol"},{"key":"2024103012241007700_CIT0108","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/art.34524","article-title":"Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease","volume":"64","author":"Semb","year":"2012","journal-title":"Arthr Rheumat"},{"key":"2024103012241007700_CIT0109","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.atherosclerosis.2014.05.248","article-title":"Rosuvastatin induced carotid plaque regression in patients with inflammatory joint diseases","volume":"235","author":"Rollefstad","year":"2014","journal-title":"Atherosclerosis"},{"key":"2024103012241007700_CIT0110","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jacc.2007.04.076","article-title":"Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis","volume":"50","author":"M\u00e4ki-Pet\u00e4j\u00e4","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2024103012241007700_CIT0111","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O\u2019gara","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2024103012241007700_CIT0112","first-page":"e344","article-title":"ACC\/AHA Task Force Members. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"2024103012241007700_CIT0113","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/annrheumdis-2011-200806","article-title":"Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort study","volume":"71","author":"Lindhardsen","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2024103012241007700_CIT0114","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/ard.2010.136093","article-title":"Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry","volume":"70","author":"Arts","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2024103012241007700_CIT0115","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1136\/annrheumdis-2014-205474","article-title":"Effect of concomitant statins on rituximab efficacy in patients with rheumatoid arthritis","volume":"73","author":"Lehane","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2024103012241007700_CIT0116","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1001\/archinte.166.21.2307","article-title":"Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials","volume":"166","author":"Thavendiranathan","year":"2006","journal-title":"Arch Intern Med"},{"key":"2024103012241007700_CIT0117"},{"key":"2024103012241007700_CIT0118"},{"key":"2024103012241007700_CIT0119"},{"key":"2024103012241007700_CIT0120"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/75\/7\/910\/60217481\/rgad024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/75\/7\/910\/60217481\/rgad024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T17:20:40Z","timestamp":1730308840000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/75\/7\/910\/7110904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":120,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7,1]]},"published-print":{"date-parts":[[2023,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgad024","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7,1]]},"published":{"date-parts":[[2023,7,1]]}}}